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ABSTRACT
Hyaline cartilage covers joint surfaces and plays an important role in reducing friction and mechanical loading on synovial joints 
such as the knee. This tissue is not supplied with blood vessels, nerves or lymphatic circulation, which may be one of the reasons 
why joint cartilage has such poor capacity for healing. Chondral lesions that reach the subchondral bone (osteochondral lesions) 
do not heal and may progress to arthrosis with the passage of time. In young patients, treatment of chondral defects of the knee 
is still a challenge, especially in lesions larger than 4 cm. One option for treating these patients is autologous chondrocyte trans-
plantation/implantation. Because this treatment does not violate the subchondral bone and repairs the defect with tissue similar 
to hyaline cartilage, it has the theoretical advantage of being more biological, and mechanically superior, compared with other 
techniques. In this paper, we describe our experience with autologous chondrocyte transplantation/implantation at the Institute of 
Orthopedics and Traumatology, Hospital das Clínicas, University of São Paulo, through a report on three cases.
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INTRODUCTION
Hyaline cartilage covers joint surfaces and plays an 
important role in reducing friction and mechanical loading 
on synovial joints such as the knee. This tissue is not sup-
plied with blood vessels, nerves or lymphatic circulation, 
which limits its capacity for healing(1). Injury to or dege-
neration of the joint cartilage diminishes its mobility and 
often causes pain on movement and, in cases of greater 
severity, causes deformities and constant pain(1,2).
Chondral lesions that reach the subchondral bone 
(osteochondral lesions) do not heal and may progress 
to arthrosis with the passage of time(3-6).
Excellent clinical results can be obtained among 
elderly patients with severe arthrosis when they tre-
ated with total knee arthroplasty. For young patients, 
no standardized treatment for chondral defects of the 
knee has yet been established in the literature, despite 
some attempts to organize such treatments in the form 
of management algorithms(7,8). Among the therapeutic 
alternatives, simple joint lavage with or without debride-
ment can be mentioned: through this, the substances and 
free bodies that degrade the cartilage and cause pain can 
be removed(9). Perforations, microfractures and abrasion 
regenerate the joint surface with tissue similar to hyaline 
cartilage (fibrocartilage), from medullary mesenchymal 
cells(10). Mosaicplasty (autologous osteochondral trans-
plantation) and autologous chondrocyte transplantation, 
also known as autologous cartilage implantation (ACI)
(9), are other treatment alternatives.
Functional units of joint cartilage are formed by 
different layers of chondral cells and by subchondral 
and spongy bone, below the cartilage. Techniques that 
interfere with the subchondral bone plate (perforations, 
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microfractures and mosaicplasty) may even reestablish 
the joint surface, but they do not restore the functional 
unit of the cartilage, especially the impact absorption 
function. Because the ACI technique does not violate 
the subchondral bone, and because it repairs the defect 
with tissue resembling hyaline cartilage, it theoretically 
has biological and mechanical advantages over other 
techniques(11), although such superiority has not been 
definitively proven. Thus, the use of this technique is 
still controversial, whether because of its high cost or 
because of the lack of definitive scientific evidence to 
justify its large-scale use.
In this paper, we describe our experience with ACI at 
the Institute of Orthopedics and Traumatology, Hospital 
das Clínicas, University of São Paulo School of Medici-
ne (IOT-HCFMUSP), through a report on three cases.
SAMPLE AND METHODS
Firstly, we describe the technique that we use for 
chondrocyte transplantation.
The procedure is carried out in two stages. Initially, a 
biopsy is taken from the cartilage and is sent for chon-
drocyte culturing (cell proliferation) in the laboratory. 
Next, cell implantation is performed. This consists of ar-
throtomy, preparation of the chondral defect, harvesting 
of periosteum, hermetic fixation of periosteum over the 
lesion using stitches and fibrin glue, injection of chon-
drocyte concentrate and closure of the operative wound.
Harvesting of cartilage for cell expansion
During the arthroscopic evaluation, the surgeon 
should perform delicate debridement of the lesion and 
remove possible free bodies and cartilage fragments 
from the joint. Only then should cartilage harvesting for 
cell expansion be performed, from areas of the femur 
that do not receive loads (superomedial and superola-
teral edges of the femoral condyles and the lateral wall 
of the intercondylar notch).
To harvest the cartilage, curettes or intervertebral 
disc biopsy tweezers are used, and three or four small 
cartilage fragments are obtained, with their thickness 
totally or partially free of subchondral bone. To achieve 
enzymatic digestion and adequate cell culturing, around 
200 to 300 mg of joint cartilage are required, correspon-
ding to around 1 cm2.
During this same procedure, 200 ml of venous blood 
should be taken from the patient. From this blood, the 
serum that will be used with the culture medium for cell 
proliferation is extracted.
In vitro cell expansion
The main objective of in vitro manipulation of 
chondrocytes is to increase the number of cells. This 
process begins with enzymatic digestion of the car-
tilage matrix, which corresponds to around 90% of 
the tissue. To proliferate the chondrocytes, monolayer 
culturing should be used. In this system, the cells 
are cultivated in 25 cm2 culturing flasks with the 
DMEM/HAMF12 culture medium supplemented with 
10% autologous serum(11). The autologous serum is 
used as a source of hormones and growth factors 
for the cultured cells. Under these condition, becau-
se of the morphological and functional changes, the 
chondrocytes acquire proliferative capacity. They are 
kept in this monolayer culturing system for a mean 
period of four weeks, in order to obtain around 10 
X 106 cells, i.e. a concentration that is considered to 
be a therapeutic dose(11).
Today, there are three generations of chondrocyte 
cultures. In the first generation, the cell culture is per-
formed as a monolayer and the cell implant in the de-
fect is covered with a piece of autologous periosteum 
(ACI-P) or with a manufactured membrane of colla-
gen I/III (ACI-C). In the second generation, after cell 
expansion in a monolayer, the cells are deposited on 
a carrier membrane/matrix, thus obtaining a membra-
ne sown with chondrocytes. In the third generation of 
ACI, the chondrocyte culture is deposited on a matrix 
of hyaluronic acid that is structured in three dimensions, 
thereby enabling homogenous distribution of the chon-
drocytes inside the lesion. Our technique consists of the 
first generation.
Second surgical stage
A standard parapatellar, medial or lateral incision 
is made and the knee is opened up by means of mini-
arthrotomy. After achieving adequate exposure, the le-
sion should be debrided, to remove all dead tissue. The 
diseases cartilage surrounding the lesion is removed, 
the chondral fissures and erosions inside the defect are 
regularized and the fibrous tissue present at the base of 
the lesion is debrided. The aim of this initial preparation 
on the defect is to obtain a lesion surrounded by healthy 
cartilage and with its base free from blood. Once the 
defect has been prepared, a mold of the lesion should be 
made, using a sheet of aluminum or sterile paper. This 
mold is used to assist in removing the periosteum graft 
in the next stage.
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Periosteum graft
The periosteum graft is obtained through an incision 
over the medial proximal tibia, around 4 cm distally 
from the goosefoot (Figure 1). The periosteum is dissec-
ted, removing all the fat and fascia on top of it. The mold 
of the lesion that were obtained earlier is positioned and 
the periosteum is marked out with the addition of 1-2 
mm on the edge. This precaution is taken because there 
is a tendency for the periosteum to shrink after harves-
ting. Next, the graft is cut on the mark that was made 
and, using a periosteum detachment device, the perios-
teal membrane is removed from the bone. The thinner 
the membrane is, the lower the risk of hypertrophy and 
fibrillation of the periosteum is. This also makes it pos-
sible to inject a greater volume of chondrocyte concen-
trate. Graft perforation during the harvesting should be 
avoided. A mark should also be made on the graft to 
identify the internal layer of the periosteum.
Suturing of the periosteum graft and 
chondrocyte implantation
The internal layer of the periosteum contains chon-
drogenic cells that, in combination with the implanted 
chondrocytes, help in producing the repair tissue. This 
layer, which was identified earlier, should be placed 
facing the bony part of the lesion and be anchored using 
separate stitches of 5-0 or 6-0 thread. These stitches 
should be made using small cutting needles, starting 
by going from outside to inside in the periosteum and 
ending by going from inside to outside in the cartilage. 
The knot is tied on the side of the periosteum, thereby 
avoiding cutting the cartilage with the thread. These 
stitches should be spaced 3-4 mm from each other, and 
Figure 1 – Removal of the periosteum graft
Figure 2 – Injection of the chondrocyte culture into the prepared 
defect
the intervals should be sealed with fibrin glue. Next, a 
check for any leakage sites is made by gently injecting 
physiological serum under the periosteum. Once the her-
metic closure of the lesion has been verified, the surgeon 
should inject the autologous chondrocyte concentrate 
into the defect (Figure 2).
The procedure is summarized in Figure 3.
During the years 2006 and 2007, three ACI procedures 
were performed by the Knee Group of IOT-HCFMUSP. 
All of these cases had chondral lesions that affected 
the entire thickness of the cartilage (Outerbridge(12) or 
International Cartilage Repair Society [ICRS](13) grade 
IV) and had not presented a satisfactory response to 
clinical treatment (of minimum duration three months) 
or to other forms of surgical treatment.
CASE 1
26-year-old male patient
This patient had presented a complaint of pain in his 
left knee for one year, without any history of trauma or 
twisting of this knee. He had the antecedent of having 
sequelae of poliomyelitis in his right leg since infancy.
On physical examination, he did not present any dis-
charge or increased volume in the affected knee. His mus-
cle strength was normal and he presented slight genu va-
rum. He had a normal range of motion and did not present 
any signs of instability or meniscal lesions. The preope-
rative clinical assessment showed a subjective IKDC of 
31.03 (percentile < 5) and a Lysholm score of 40.
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On imaging examinations, he presented a lesion 
compatible with osteochondritis dissecans in the medial 
femoral condyle, in the loading area. This lesion was 
confirmed by magnetic resonance examination, which 
also showed that fixation of the fragment would be im-
possible. A panoramic radiograph on the legs showed a 
mechanical axis of eight degrees of varus.
Initially, non-operative treatment methods were ins-
tituted, using analgesic and chondral protective medi-
cations, physiotherapy and removal of the mechanical 
overload, but without success. Since the patient did not 
present any improvement, it was decided to proceed 
with surgical treatment.
The patient underwent arthroscopic surgery to re-
move a cartilage sample outside of the loading area, 
from the lateral part of the femoral trochlea. During 
this procedure, the lesion could be viewed: it presented 
a total area of 5 cm2 of detached cartilage, without any 
significant subchondral bone defect (< 5 mm). The car-
tilage sample was sent for culturing in order to multiply 
the chondral cells.
Thirty-five days later, the patient underwent the se-
cond stage of chondrocyte transplantation, together with 
osteotomy for varus correction.
Six months later, the patient underwent surgery again, 
to remove the plate, with arthroscopy again, to inspect 
the transplanted area.
CASE 2
40-year-old male patient
This patient had a history of pain in his left knee that 
began seven years earlier, after twisting his knee during 
sports practice.
He started to be followed up at our service three 
years after the event. At that time, he was diagnosed as 
presenting a medial meniscal lesion and, for this reason, 
he underwent partial meniscectomy of the posterior cor-
nu of the medial meniscus. Initially, he responded well 
to the treatment, but one year later, he evolved with 
new complaints of pain in the knee. It was decided to 
perform arthroscopy again, and revision of the menis-
cectomy was performed. A diagnosis of complete chon-
dral lesion (grade IV), measuring 1 cm2 on the medial 
femoral condyle in the loading area, was made. During 
the same operation, the chondral defect was perforated 
(microfracture technique) as a form of treatment.
The evolution was unsatisfactory and the patient con-
tinued to present a condition of medial pain in the knee. 
Thus, two and a half years later, he was again referred 
to the surgical center to undergo valgizing osteotomy 
of the tibia, in order to correct the varus, along with the 
first stage of chondrocyte transplantation, for harvesting 
of healthy cartilage. The preoperative assessment at this 
time revealed a subjective IKDC 28.74 (percentile < 5) 
and a Lysholm score of de 75.
Figure 3 – Schematic drawing of the autologous chondrocyte transplantation/implantation procedure (Brittberg, 1994)(11)
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The second stage of chondrocyte transplantation was 
performed 45 days later, with implantation of cultured 
cells into the chondral defect.
CASE 3
33-year-old patient
The patient had a history of pain in the left knee that 
started 20 years earlier, after mild trauma during adoles-
cence. The pain had been mild, without functional limita-
tions until six months before treatment started at our ser-
vice, when a progressive worsening of the pain began.
Magnetic resonance performed at the start of the 
follow-up revealed a large osteochondral lesion in the 
loading area of the medial femoral condyle, with a bone 
fragment that had detached and dislocated. Since the 
anatomical lesion was significant and there had been no 
improvement over the six months of treatment outside of 
our service, it was decided to treat the case surgically, by 
means of chondrocyte transplantation. The preoperative 
clinical evaluation revealed a subjective IKDC of 24.14 
(percentile < 5) and a Lysholm score of 39.
The first stage of ACI was undertaken with removal 
of healthy cartilage for culturing.
The second stage of the chondrocyte transplantation 
was carried out 34 days later, by means of knee arthro-
tomy. Since the lesion was not just cartilaginous and 
there was bone loss from the base of the lesion, it was 
decided to perform grafting from the iliac to fill this 
bone defect. The spongy bone was covered by a layer of 
periosteum that was sutured to the surrounding cartilage. 
The cultured cells were implanted on this periosteum 
and were, in turn, covered by another layer of perios-
teum (“sandwich” technique). During this same opera-
tion, the detached osteochondral fragment (free body) 
was removed, for which fixation was impossible.
RESULTS
Case 1 was 26 years of age at the time of the chon-
drocyte transplantation surgery and had a chondral le-
sion of non-traumatic origin (osteocondritis dissecans) 
that had been present for around one year. The lesion 
had a large area, of 5 cm2, on the medial femoral con-
dyle in a loading area. The patient presented associated 
conditions of genu varum and sequelae of poliomyelitis 
in the contralateral limb. The preoperative clinical asses-
sment revealed a subjective IKDC of 31.03 (percentile 
< 5) and a Lysholm score of 40. In the postoperative 
clinical evaluation, with 12 months of follow-up, the 
patient presented an IKDC score of 57.47 (percentile 
< 5) and a Lysholm score of 70. Although the patient 
reported improvements in the symptoms, the painful 
condition was maintained.
Case 2 was 40 years of age at the time of the chon-
drocyte transplantation surgery and had a chondral le-
sion of traumatic origin that had been present for a long 
time (around eight years). The lesion area was 1 cm2, on 
the medial femoral condyle in a loading area. In associa-
tion with this, the patient had a medial meniscal lesion 
and genu varum. The preoperative clinical assessment 
showed a subjective IKDC of 28.74 (percentile < 5) 
and a Lysholm score of 75. In the postoperative clinical 
assessment, after 18 months of follow-up, the patient 
presented an IKDC score of 49.43 (percentile = 5) and 
a Lysholm score of 94. Although the patient reported 
improvements in the symptoms, a significant painful 
condition was maintained.
Case 3 was 33 years of age at the time of the chon-
drocyte transplantation surgery and had a chondral le-
sion of non-traumatic origin that had been present for a 
long time (around 20 years). The lesion area was 5 cm2, 
on the medial femoral condyle in a loading area. There 
were no associated lesions. The preoperative clinical 
assessment revealed a subjective IKDC of 24.14 (per-
centile < 5) and a Lysholm score of 39. In the postope-
rative clinical evaluation, with 16 months of follow-up, 
the patient presented an IKDC score of 60.92 (percentile 
10) and a Lysholm score of 84. Although the patient 
reported improvements in the symptoms, the painful 
condition was maintained.
DISCUSSION
Autologous chondrocyte transplantation/implanta-
tion (ACI) is considered to be a treatment option for 
lesions affecting the total thickness of the joint cartilage 
(Outerbridge(12) or International Cartilage Repair Socie-
ty [ICRS](13) grade IV).
ACI should be considered to be second-line treatment 
for chondral defects < 2 cm2 and should only be used 
when other, simpler techniques such as microfractures 
fail. On the other hand, if the defects are larger than 2 
cm2, ACI can be used as the initial treatment option(7). 
The location of the defect should be on the femoral 
or patellar joint surface and should be accessible by 
means of open arthrotomy. A definitive indication for 
using ACI should only be considered during arthrosco-
pic assessment. This procedure is the best determinant 
454
Rev Bras Ortop. 2010;45(4):449-56
of the location, depth and size of the defect, as well as 
proving assessments of the quality of the surrounding 
cartilage and the state of the chondral surface opposite 
the lesion(14,15). For the best results to be obtained from 
the technique, it is fundamentally important not to have 
mechanical overload on the cartilage. Thus, any varus 
and valgus deformities that patients may present, and 
any ligament instability (anteroposterior, collateral and 
patellar), should be corrected before the ACI procedure, 
or else there may be a risk of treatment failure(16).
Conditions of severe osteoarthritis and the presen-
ce of bipolar lesions (kissing lesions) or bone-on-bone 
lesions (lesions through the joint, i.e. femur and tibia) 
are considered to be contraindications for ACI(14). For 
this reason, in addition to the physical examination, a 
radiograph of the knee using the view described by Ro-
senberg et al(17) (anteroposterior view of the knee with 
loading and flexed at 45°) should be obtained in order 
to rule out advanced degenerative joint disease. Other 
contraindications are rheumatoid arthritis or other active 
autoimmune diseases of connective tissue, and malig-
nant neoplasia(14).
It is essential for candidates for ACI to go through an 
arthroscopic evaluation: this is a fundamental stage for 
preoperative planning. Magnetic resonance images still 
do not have sufficient sensitivity and specificity to evalu-
ate certain chondral lesions. In addition, only arthroscopy 
enables direct viewing and palpation of the joint cartilage, 
and thus is able to diagnose changes to its consistency 
and possible partial delamination. Only arthroscopic exa-
mination of the knee makes it possible to exactly deter-
mine the size and depth of the chondral defect, and the 
quality of the cartilage that surrounds it(8,14).
Among the cases presented here, there were two pa-
tients with a diagnosis of osteochondritis of large area (5 
cm2), while the remaining case had a traumatic chondral 
lesion of small area (1 cm2). The first and third cases 
went straight for ACI treatment because of the size of 
the lesion, while the second case firstly underwent an 
unsuccessful attempt at treatment by means of micro-
fractures, which is the preferred choice for lesions of 
that size. The first two cases presented genu varum with 
deformity < 10º, and both of them underwent correction 
of this deviation, in order to maximize the clinical re-
sults. In case 1, osteotomy with lateral wedge closure 
was chosen, since this patient presented shortening of 
the opposite side as a sequela of poliomyelitis. In case 
2, valgizing osteotomy with Puddu medial wedge ope-
ning was chosen. None of the cases presented relevant 
postoperative complications.
Peterson et al(18) followed up 58 patients with a diag-
nosis of osteochondritis dissecans who were treated with 
ACI, for a mean of 5.6 years. Among these patients, 
some of whom with bone defects greater than 10 mm 
in depth, 91% had good or excellent clinical results. 
However, the current recommendation is to use grafts 
in bone defects larger than 8 mm(19). In a study that 
evaluated 244 patients, with clinical follow-up for 2-10 
years, notable subjective and objective clinical impro-
vements were observed when ACI treatment was used. 
A large proportion of these patients had femoral condyle 
lesions or osteocondritis dissecans. There was a high 
rate of good and excellent results (84-90%) among the 
patients with isolated femoral condyle lesions. On the 
other hand, the rate was low (mean of 74%) among 
those with other types of lesion (patellar, trochlear and 
multiple lesions)(16). To study the long-term durability 
of ACI, 61 patients were followed up for 5-11 years 
(mean of 7.4 years), after the surgery. After two years, 
50 of the 61 patients had good or excellent results, and 
after 5-11 years of evolution, 51 of the 61 patients were 
graded as good and excellent results. The total failure 
rate was 16% (10/61 patients), among which all the ACI 
failure occurred in the first two years. Thus, the high 
percentage of patients with good and excellent results 
over the first two years remained well for a long period 
of postoperative follow-up(16).
Many authors have compared the ACI technique 
with other cartilage repair procedures, but only a few 
of them were able to design studies with a notable de-
gree of clinical evidence. In general, the evidence does 
not prove that ACI is superior to the microfracture and 
mosaicplasty techniques, for example(2,20-22).
With regard to the clinical results from the cases ope-
rated in our service, we only observed a slight improve-
ment in the patients’ conditions. The indication of ACL 
in case 1 can be questioned, given that the presence of 
sequelae from poliomyelitis in the opposite leg was a 
significant overload factor for the operated knee, althou-
gh this would be true for any other surgical option for 
chondral lesion treatment. Nevertheless, this overload 
may have compromised the clinical results from the 
treatment. Case 2 also presented an insignificant im-
provement in pain symptoms, although this patient also 
had an overload factor in the chondral repair: partial me-
niscectomy of the medial meniscus. Thus, we consider 
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that the results obtained are not discouraging, since it is 
likely that the improvement would have been even more 
significant in ideal cases, although ideal situations are 
rarely achieved in treating chondral lesions. We consider 
that the reported pain was due not only to the chondral 
lesion but also to other factors present in these patients, 
which limited the improvement in pain.
Another point that needs to be made is in relation to 
the costs and the low availability of the technique. There 
is no doubt that ACI should preferably be considered to 
be a second choice in treating chondral lesions, given 
that it costs much more than microfracture (which is 
considered to be the preferred technique for the initial 
surgical approach in most cases of complete chondral 
lesions) and requires two surgical procedures (including 
the fact that one of them is an open procedure). Moreo-
ver, it has extremely low availability in Brazil.
Maci (Verigen AG, Leverkusen, Germany)(23), 
which is considered to be a second-generation techni-
que, and Hyalograft-C (Fidia Advanced Biopolymers, 
Abano Term, Italy)(24,25), which is considered to be a 
third-generation technique, are examples of advances 
in chondrocyte implantation. Maci uses a matrix of 
collagen type I/III to sow chondrocytes in a double 
layer. Hyalograft-C uses a 3-D matrix of hyaluronic 
acid, which functions as a support for the growth of 
chondrocytes in vitro. These matrixes containing chon-
drocytes are implanted on the chondral lesion and atta-
ched using fibrin glue. In this way, periosteum grafts are 
not needed, and hence no suturing onto healthy cartilage 
is needed, either. These techniques have been developed 
in an attempt to resolve one of the commonest problems 
shown by the ACI technique(19): hypertrophy of the pe-
riosteum, which is a reason for complaints of localized 
pain among some patients.
CONCLUSION
We conclude that autologous chondrocyte transplan-
tation/implantation is an option for treating extensive 
chondral lesions or after the failure of simpler tech-
niques for smaller chondral lesions, even though the 
improvement was only partial in our patients.
We emphasize that we do not consider the ACI techni-
que to be the preferred option for the initial management 
of complete chondral lesions, because of its high cost, gre-
ater complexity, need for two hospitalizations, low avai-
lability and lack of international consensus regarding its 
results, in relation to other techniques that are available.
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